Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome
about
Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studiesSmoking and the outcome of infection.A cost-effectiveness analysis of "test" versus "treat" patients hospitalized with suspected influenza in Hong KongEffectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in ChinaTwo years after pandemic influenza A/2009/H1N1: what have we learned?The 2009 influenza A (H1N1) pandemic: what have we learned in the past 6 months.Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005-2008.Age-prioritized use of antivirals during an influenza pandemic.Clinical Outcome of Novel H1N1 (Swine Flu)-Infected Patients During 2009 Pandemic at Tertiary Referral Hospital in Western India.[Factors related to death by the Pandemic Influenza A (H1N1) 2009 in patients treated with oseltamivir].Influenza virus-induced lung inflammation was modulated by cigarette smoke exposure in mice.Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital.Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies2009 H1N1 influenza.Point of care strategy for rapid diagnosis of novel A/H1N1 influenza virus.Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection.Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.Factors associated with death in hospitalized pneumonia patients with 2009 H1N1 influenza in Shenyang, China.Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patientsRisk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in ChinaClinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults.Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009.Factors associated with death or intensive care unit admission due to pandemic 2009 influenza A (H1N1) infectionClinical features, complications and mortality in critically ill patients with 2009 influenza A(H1N1) in Sfax,TunisiaAntiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virusPeramivir for the treatment of influenza.Impact of antiviral treatment and hospital admission delay on risk of death associated with 2009 A/H1N1 pandemic influenza in Mexico.Risk factors for mortality among 2009 A/H1N1 influenza hospitalizations in Maricopa County, Arizona, April 2009 to March 2010Neuraminidase inhibitors for influenza: a review and public health perspective in the aftermath of the 2009 pandemic.Influenza vaccination guidelines and vaccine sales in southeast Asia: 2008-2011Influenza A(H1N1)pdm09-associated pneumonia deaths in ThailandThe characteristics, clinical manifestations and outcomes of pandemic influenza A (H1N1) 2009 in the elderly.Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: clinical and economic impactA comparison of clinical and epidemiological characteristics of fatal human infections with H5N1 and human influenza viruses in Thailand, 2004-2006.Epidemiology of influenza-associated hospitalization in adults, Toronto, 2007/8.Reducing the burden of acute respiratory distress syndrome: the case for early intervention and the potential role of the emergency department.The convergence of the global smoking, COPD, tuberculosis, HIV, and respiratory infection epidemics.Cigarette smoke attenuates the RIG-I-initiated innate antiviral response to influenza infection in two murine models.Prevalence of influenza A/H3N2 virus in northern Iran from 2011 to 2013Alteration of the nasal responses to influenza virus by tobacco smoke
P2860
Q26852067-B6B38FAA-A7CA-4170-8750-440044332162Q27687123-F05809A7-7370-40D2-B3AD-1708BF685C6AQ28730856-8A669089-19F9-4729-8E88-DDAF69C055C3Q28749090-DF84BC8F-B9A6-4438-9B0D-E146D19525AEQ30224656-F8A39B28-6AFF-41FC-B827-FF6B501CB92FQ30227033-C74C4935-8FAB-49AB-BDD1-6A999C127E52Q30227419-5FB3C8FF-EB68-44F1-9431-5701991CB941Q30227718-2EED21E8-47F3-49F8-8475-6BDA700D5EEEQ30353760-5AFD5670-98A6-4BEF-A107-1BBB6E99C88EQ30355484-74036D91-5641-42E6-A895-DB28AAF5CC77Q30358340-0B32419A-A6AD-486E-81FC-CAFFECAB2945Q30358632-02770E88-E04E-4E74-A330-A3DCBC321D0EQ30364474-4FA4846C-C7DC-4357-A560-9956730B93A6Q30383437-404B42AF-0E11-4294-B817-F4486C85DC28Q30383697-092E8B91-C581-408C-A994-85929586A0FAQ30384722-8103CD34-BF99-494D-B782-DB924307ED1BQ30388312-26EBD26D-3F56-4290-A6E2-48CEBA329479Q30389844-94EDADE4-60BC-49E8-9FC8-BE580DEFE318Q30395003-BCBF8F93-48D1-4209-A4B1-C77DDC7DB95EQ30398438-AA3CF093-3044-4F4F-ACB0-69055EF4CE21Q30398779-2741AB50-5329-4C7F-8337-38F64799F9D3Q30401124-32CC7CEA-884D-4305-8E69-B5E58D76D107Q30402682-BD0FF597-F93C-4855-A19F-DC33AE186D9FQ30403551-912F81CB-A619-48A5-BB37-943808AFCB7CQ30412188-B4BFB2D3-EB91-46B5-B2EC-120D450D75D5Q30413154-ECB8128D-DA02-4DFF-8B46-A1BB315F8B76Q30415719-B0B5BAE9-2920-472F-8210-D0F30F76B40DQ30419774-E27115DE-26E6-4A22-9CAC-E7AFA458655DQ30425347-8D5A1A29-8936-48EF-B631-137167AC0B01Q30425469-B54C95C7-1079-41C3-886B-0B0866DA79F3Q30426906-0116905E-BCAE-44EF-9256-D87925AA8512Q30431507-6AB39E34-4E7D-4566-AFD6-BFDA0624C537Q33520449-82A2C2D8-8292-43B1-8B6F-EEE916440A9EQ33894593-84775A31-620F-460B-8216-393F4D43B1DEQ33928241-5AAE0D39-ED66-4D80-AD39-EBF78C24DB50Q33940879-95B7887D-7C52-4637-9385-81C462E78251Q34039460-9BD1A896-4ED4-40A6-864B-B94577BDDE76Q34627530-75C9FC09-D47C-474B-A3CA-11052AD1EC70Q35773706-4445C916-B787-4B83-83AE-FC7FDCFA2083Q35835252-49EA6057-E052-4E20-A04A-EE97A2D9888E
P2860
Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Severe human influenza infecti ...... risk factors for fatal outcome
@ast
Severe human influenza infecti ...... risk factors for fatal outcome
@en
type
label
Severe human influenza infecti ...... risk factors for fatal outcome
@ast
Severe human influenza infecti ...... risk factors for fatal outcome
@en
prefLabel
Severe human influenza infecti ...... risk factors for fatal outcome
@ast
Severe human influenza infecti ...... risk factors for fatal outcome
@en
P2093
P2860
P1433
P1476
Severe human influenza infecti ...... risk factors for fatal outcome
@en
P2093
Darin Areechokechai
James Mark Simmerman
Suchada Kaewchana
Ubolrat Narueponjirakul
Vivek Shinde
Wiwan Sanasuttipun
P2860
P356
10.1371/JOURNAL.PONE.0006051
P407
P577
2009-06-25T00:00:00Z